In practical terms, PDE5 inhibitors for erectile dysfunction after SCI represent the most consistent signal, whereas most psychobehavioral, physiotherapy-based, and multidisciplinary interventions are supported by small trials with heterogeneous outcomes and limited follow-up, which constrains both generalizability and durability of effects. This evidence concerns the gene PDE5A and erectile dysfunction.